Literature DB >> 24578595

Hypertrophic cardiomyopathy in the Saudi Arabian population: Clinical and echocardiographic characteristics and outcome analysis.

Waqas Ahmed1, Naveed Akhtar1, Odd Bech-Hanssen1, Bader Al Mahdi1, Talal Al Otaibi1, Bahaa M Fadel1.   

Abstract

BACKGROUND: Current published literature on hypertrophic cardiomyopathy (HCM) comes primarily from Western populations. There is no published data on clinical and echocardiographic characteristics and long-term outcome of HCM in an Arab population.
METHODS: We conducted a retrospective analysis of all patients 16 years or older diagnosed with HCM at our institution. Detailed clinical and echocardiographic data were collected and outcome was analyzed.
RESULTS: A total of 69 patients were identified as having HCM. The mean age was 42 ± 16 years with 71% male patients. All patients were Saudi citizens with Arab ancestry. Details about family history and presenting symptoms were available for 44 and 48 patients consecutively. Nine (18%) patients were asymptomatic and were diagnosed based on abnormal cardiac auscultation. The commonest presenting symptoms were dyspnea with or without chest pain and palpitations occurring in 40 (81%) patients. Only four (9%) of 44 patients had a family history of HCM and /or sudden cardiac death (SCD). The most common ECG abnormality was left ventricular hypertrophy (LVH) present in 60 (86%) patients. The commonest septal hypertrophy morphology was mid-septal (catenoid) in 30 (43%) followed by neutral in 23 (33%), basal septal (sigmoid) in 3 (4%) and apical in 6 (8%) patients. Twenty (28%) patients had evidence of resting left ventricular cavity gradient of ⩾30 mmHg. Eleven (16%) patients had evidence of biventricular hypertrophy. Left ventricular ejection fraction was normal in 65 (94%) patients. Over a median (25-75 percentile) follow-up of 7 years (4.5-10), only three patients died, all of non-cardiac causes. There were no cases of SCD during the follow-up period. Six patients required an implantable cardioverter-defibrillator (ICD); five for primary prevention and one for secondary prevention. Only one patient progressed to end stage dilated cardiomyopathy.
CONCLUSION: The natural history of hypertrophic cardiomyopathy in the Saudi population appears to be benign with catenoid morphology being the most common septal hypertrophy pattern. Risk of SCD appears to be quite low in this population.

Entities:  

Keywords:  Echocardiography; Hypertrophic cardiomyopathy; Outcome; Septal morphology

Year:  2013        PMID: 24578595      PMCID: PMC3936241          DOI: 10.1016/j.jsha.2013.08.003

Source DB:  PubMed          Journal:  J Saudi Heart Assoc        ISSN: 1016-7315


  23 in total

1.  Hypertrophic cardiomyopathy: an important global disease.

Authors:  Barry J Maron
Journal:  Am J Med       Date:  2004-01-01       Impact factor: 4.965

Review 2.  Recommendations for the evaluation of left ventricular diastolic function by echocardiography.

Authors:  Sherif F Nagueh; Christopher P Appleton; Thierry C Gillebert; Paolo N Marino; Jae K Oh; Otto A Smiseth; Alan D Waggoner; Frank A Flachskampf; Patricia A Pellikka; Arturo Evangelista
Journal:  J Am Soc Echocardiogr       Date:  2009-02       Impact factor: 5.251

3.  Anatomic and clinical correlates of septal morphology in hypertrophic cardiomyopathy.

Authors:  Aslan T Turer; Zainab Samad; Anne Marie Valente; Michele A Parker; Brenda Hayes; Raymond J Kim; Joseph Kisslo; Andrew Wang
Journal:  Eur J Echocardiogr       Date:  2010-11-01

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.

Authors:  F Cecchi; I Olivotto; A Montereggi; G Santoro; A Dolara; B J Maron
Journal:  J Am Coll Cardiol       Date:  1995-11-15       Impact factor: 24.094

6.  Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance.

Authors:  A Selcuk Adabag; Barry J Maron; Evan Appelbaum; Caitlin J Harrigan; Jacqueline L Buros; C Michael Gibson; John R Lesser; Constance A Hanna; James E Udelson; Warren J Manning; Martin S Maron
Journal:  J Am Coll Cardiol       Date:  2008-04-08       Impact factor: 24.094

7.  Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990.

Authors:  C R Cannan; G S Reeder; K R Bailey; L J Melton; B J Gersh
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

8.  Asymmetric apical hypertrophy: ten years experience.

Authors:  T Sakamoto; K Amano; Y Hada; C Tei; K Takenaka; I Hasegawa; T Takahashi
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

9.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults.

Authors:  Yubao Zou; Lei Song; Zhimin Wang; Aiqun Ma; Tangwei Liu; Huimin Gu; Sailan Lu; Pengzhu Wu; Ying Zhang dagger; Li Shen dagger; Yuling Cai; Yisong Zhen double dagger; Yanling Liu; Rutai Hui
Journal:  Am J Med       Date:  2004-01-01       Impact factor: 4.965

10.  Clinical course of hypertrophic cardiomyopathy with survival to advanced age.

Authors:  Barry J Maron; Susan A Casey; Robert G Hauser; Dorothee M Aeppli
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

View more
  1 in total

1.  Clinical features, spectrum of causal genetic mutations and outcome of hypertrophic cardiomyopathy in South Africans.

Authors:  Ntobeko A Ntusi; Gasnat Shaboodien; Motasim Badri; Freedom Gumedze; Bongani M Mayosi
Journal:  Cardiovasc J Afr       Date:  2016 May/Jun       Impact factor: 1.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.